Inaccuracies don’t just erode trust — they lead directly to surprise billing events, missed appointments, care delays, and in some cases, enforcement action. The post Beyond Broken Links: The High Stakes of Provider Directory Accuracy in the No Surprises Era appeared first on MedCity News.
A systemic change from FFS to VBC would represent more than a payment model switch, but rather a holistic transition toward patient-centered healthcare that prioritizes outcomes over activity. The post From Fee-for-Service to Value-Based Care: Enhancing Outcomes in Nephrology appeared first on MedCity News.
Dizal Pharmaceutical’s Zegfrovy is now FDA approved for treating non-small cell lung cancer driven by a particular rare genetic signature. Johnson & Johnson drug Rybrevant already addresses this genetic signature as an earlier line of therapy, but Dizal executives contend their drug offers the potential for better safety and efficacy. The post With FDA Nod…
This week, CMS established a reimbursement code for Eko Health’s AI platform, which seeks to aid clinicians in the diagnosis of heart conditions. The goal behind the technology is to help catch heart disease earlier, when it’s easier to treat, and to make high quality diagnostic care more accessible. The post Eko Health’s AI for…
It became clear to me that if my father’s life could be drastically improved with routine at-home care, so could many others. The next frontier in healthcare isn’t just about new medications or diagnostic tools; it’s about reimagining how and where we deploy our existing clinical expertise. The post What Administering My Father’s Home Infusions…
But where do truth and trust originate in healthcare marketing? They emerge from various sources such as digital advertising, educational campaigns, patient journeys, and partnerships with healthcare providers who uphold truth in advertising standards. The post From Magic Bullets to Medical Insights: How RFK Jr.’s Critique Shapes the Future of Pharma Advertising appeared first on…
Now is the time for senior living leaders to act and re-imagine what resident-centered, modern care can look like, today and in the future. The post AI Is No Longer Optional in Senior Living – Here’s Why appeared first on MedCity News.
Success with agentic AI won’t come from racing to adopt the flashiest tools. It will come from strategic alignment, understanding where AI can create real value, mitigating risk through thoughtful implementation, and ensuring transparency and oversight at every step. The post From Hype to Impact: How Pharma Can Use Agentic AI to Drive Efficiency and…
[Sponsored] AI-powered threats are overwhelming outdated IT defenses. Discover why email remains healthcare’s biggest cybersecurity vulnerability and what can be done to address it. The post AI-Driven Email Attacks Are Exploding. Is Your Healthcare Organization at Risk? appeared first on MedCity News.
Bispecific antibodies are already available for treating multiple myeloma. FDA approval of Regeneron Pharmaceuticals’ new drug, Lynozyfic, comes with dosing flexibility that sets it apart from others in its class. The post FDA Approves Regeneron Multiple Myeloma Drug With Dosing Edge Over J&J and Pfizer Meds appeared first on MedCity News.